Quantcast
Home » Topics » Novo Nordisk

Supreme Court ruling supports generic drug makers

WASHINGTON — The US Supreme Court ruled that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions. The measure overturns a 2010 appeals court ruling and confirms an earlier decision by a federal judge that ordered the US…

Google+